A phase 1b/2 trial shows that #allogeneic #NKcell therapy plus #chemotherapy is safe in #AdvancedPancreaticCancer, with 31.6% response; #MultiomicProfiling reveals NK/T‑cell subsets linked to outcomes, offering novel immune insights.
#OpenAccess in STTT: doi.org/10.1038/s413...
#OpenAccess in STTT: doi.org/10.1038/s413...
January 28, 2026 at 4:07 PM
A phase 1b/2 trial shows that #allogeneic #NKcell therapy plus #chemotherapy is safe in #AdvancedPancreaticCancer, with 31.6% response; #MultiomicProfiling reveals NK/T‑cell subsets linked to outcomes, offering novel immune insights.
#OpenAccess in STTT: doi.org/10.1038/s413...
#OpenAccess in STTT: doi.org/10.1038/s413...
Living With Advanced Pancreatic Cancer: Patients' Experiences of Daily Life.
Bergqvist, Jenny, Bernhardson, Britt-Marie et al.
Paper
Details
#AdvancedPancreaticCancer #PatientsExperiences #DailyLifeWithCancer
Bergqvist, Jenny, Bernhardson, Britt-Marie et al.
Paper
Details
#AdvancedPancreaticCancer #PatientsExperiences #DailyLifeWithCancer
September 4, 2025 at 8:56 PM
Living With Advanced Pancreatic Cancer: Patients' Experiences of Daily Life.
Bergqvist, Jenny, Bernhardson, Britt-Marie et al.
Paper
Details
#AdvancedPancreaticCancer #PatientsExperiences #DailyLifeWithCancer
Bergqvist, Jenny, Bernhardson, Britt-Marie et al.
Paper
Details
#AdvancedPancreaticCancer #PatientsExperiences #DailyLifeWithCancer
New Jersey Patients Receiving First-of-Its-Kind Catheter Based Pancreatic Cancer Treatment
www.newswise.com/articles/new...
#oncology #advancedpancreaticcancer #pancreaticcancer #hepatobiliarysurgery #fdacleareddevice #SurgicalOncology #academicmedicalcenter #newjersey #targetedcancertherapy
www.newswise.com/articles/new...
#oncology #advancedpancreaticcancer #pancreaticcancer #hepatobiliarysurgery #fdacleareddevice #SurgicalOncology #academicmedicalcenter #newjersey #targetedcancertherapy
April 17, 2025 at 3:52 AM
New Jersey Patients Receiving First-of-Its-Kind Catheter Based Pancreatic Cancer Treatment
www.newswise.com/articles/new...
#oncology #advancedpancreaticcancer #pancreaticcancer #hepatobiliarysurgery #fdacleareddevice #SurgicalOncology #academicmedicalcenter #newjersey #targetedcancertherapy
www.newswise.com/articles/new...
#oncology #advancedpancreaticcancer #pancreaticcancer #hepatobiliarysurgery #fdacleareddevice #SurgicalOncology #academicmedicalcenter #newjersey #targetedcancertherapy
www.linkedin.com/pulse/fda-ap...
FDA Approves Bizengri for Targeted Therapy in Advanced Pancreatic and Lung Cancer
kstrategyand.com/pharma-news
#Bizengri #FDAApproval #AdvancedPancreaticCancer #NSCLC #CancerTreatment #TargetedTherapy #NRG1GeneFusion #Humanteconomy #Humantec #KStrategyand
FDA Approves Bizengri for Targeted Therapy in Advanced Pancreatic and Lung Cancer
kstrategyand.com/pharma-news
#Bizengri #FDAApproval #AdvancedPancreaticCancer #NSCLC #CancerTreatment #TargetedTherapy #NRG1GeneFusion #Humanteconomy #Humantec #KStrategyand
FDA Approves Bizengri for Targeted Therapy in Advanced Pancreatic and Lung Cancer
Merus has achieved a significant milestone with the FDA’s accelerated approval of Bizengri (zenocutuzumab-zbco), making it the first-ever approved treatment for advanced pancreatic adenocarcinoma and ...
www.linkedin.com
January 9, 2025 at 10:29 AM
www.linkedin.com/pulse/fda-ap...
FDA Approves Bizengri for Targeted Therapy in Advanced Pancreatic and Lung Cancer
kstrategyand.com/pharma-news
#Bizengri #FDAApproval #AdvancedPancreaticCancer #NSCLC #CancerTreatment #TargetedTherapy #NRG1GeneFusion #Humanteconomy #Humantec #KStrategyand
FDA Approves Bizengri for Targeted Therapy in Advanced Pancreatic and Lung Cancer
kstrategyand.com/pharma-news
#Bizengri #FDAApproval #AdvancedPancreaticCancer #NSCLC #CancerTreatment #TargetedTherapy #NRG1GeneFusion #Humanteconomy #Humantec #KStrategyand